These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3023306)

  • 1. Human mammary cancer cell mutants with altered hormone receptor activity.
    Ueda H; Hagino Y; Ono M; Kuwano M
    J Biochem; 1986 Aug; 100(2):341-8. PubMed ID: 3023306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
    Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
    Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
    Bronzert DA; Greene GL; Lippman ME
    Endocrinology; 1985 Oct; 117(4):1409-17. PubMed ID: 4029083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture.
    Nawata H; Chong MT; Bronzert D; Lippman ME
    J Biol Chem; 1981 Jul; 256(13):6895-902. PubMed ID: 7240250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.
    Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L
    J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7.
    Roos W; Oeze L; Löser R; Eppenberger U
    J Natl Cancer Inst; 1983 Jul; 71(1):55-9. PubMed ID: 6575210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells.
    Berkenstam A; Glaumann H; Martin M; Gustafsson JA; Norstedt G
    Mol Endocrinol; 1989 Jan; 3(1):22-8. PubMed ID: 2915647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of progesterone receptor by 17 beta estradiol and tamoxifen in the Zr-75-1 human breast cancer cell line in defined medium.
    Allegra JC; Korat O; Do HM; Lippman M
    J Recept Res; 1981; 2(1):17-27. PubMed ID: 6270327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ; Jordan VC
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.
    Dumont JA; Bitonti AJ; Wallace CD; Baumann RJ; Cashman EA; Cross-Doersen DE
    Cell Growth Differ; 1996 Mar; 7(3):351-9. PubMed ID: 8838865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro.
    Danforth DN; Sgagias MK
    Cancer Res; 1991 Mar; 51(5):1488-93. PubMed ID: 1997187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of retinoic acid-resistant clones from human breast cancer cell line MCF-7 with altered activity of cellular retinoic acid-binding protein.
    Ueda H; Ono M; Hagino Y; Kuwano M
    Cancer Res; 1985 Jul; 45(7):3332-8. PubMed ID: 2988768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.